ArticleCureus2025
Physician Specialty, Experience, Region, Gender, and the Socioeconomic Status of Practice Location Predict Cost of Skin Cancer Procedures Performed in the Medicare Population.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSkin cancer affects approximately five million individuals annually in the United States, with nonmelanoma skin cancers (NMSC) and melanoma amounting to $8.9 billion in annual healthcare costs.
objectiveGiven the growing financial burden on the Medicare population, the present study aims to identify cost predictors to help detect outlier physician behavior and reduce healthcare costs. MATERIALS AND
methodsUsing Medicare payments from 2017-2021, we analyzed malignant destructions and excisions (collectively, "removals") and cutaneous closures on the trunk, arms, and legs. We included physicians from seven specialties and analyzed physician gender, years of experience, region, and socioeconomic status indicators. We subdivided physicians into three specialty subgroups, dermatologists, surgeons, and generalists, and characterized their overall case volume and costs. Then, adjusting for procedure type and volume, we calculated differences between actual and database-wide expected procedural costs and used k-means clustering to group physician cost patterns.
resultsPrior to adjustments, dermatologists billed higher-than-expected for removals, while surgeons had higher-than-expected total closure costs. However, with subsequent weighted adjustments, cluster analysis identified four unique physician cost phenotypes. Clustering demonstrated male physician gender, more experience, and practice in the Northeast, West, and affluent areas predicted high costs, while lower costs were associated with dermatologists and Midwestern practitioners. Between the highest and lowest cost clusters, the summed cost for a removal and closure differed by up to $1,735.
conclusionPhysician and practice characteristics predict substantial cost differences, highlighting the need to understand these variations to optimize cost-effective skin cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.